| 000 | 01758 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513214621.0 | ||
| 264 | 0 | _c20001121 | |
| 008 | 200011s 0 0 eng d | ||
| 022 | _a0954-691X | ||
| 024 | 7 |
_a10.1097/00042737-200012060-00020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPetroni, M L | |
| 245 | 0 | 0 |
_aRisk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group. _h[electronic resource] |
| 260 |
_bEuropean journal of gastroenterology & hepatology _cJun 2000 |
||
| 300 |
_a695-700 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aChenodeoxycholic Acid _xtherapeutic use |
| 650 | 0 | 4 |
_aCholagogues and Choleretics _xtherapeutic use |
| 650 | 0 | 4 |
_aCholelithiasis _xtherapy |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLithotripsy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aUrsodeoxycholic Acid _xtherapeutic use |
| 700 | 1 | _aJazrawi, R P | |
| 700 | 1 | _aPazzi, P | |
| 700 | 1 | _aZuin, M | |
| 700 | 1 | _aLanzini, A | |
| 700 | 1 | _aFracchia, M | |
| 700 | 1 | _aFacchinetti, D | |
| 700 | 1 | _aAlvisi, V | |
| 700 | 1 | _aFerraris, R | |
| 700 | 1 | _aBland, J M | |
| 700 | 1 | _aHeaton, K W | |
| 700 | 1 | _aPodda, M | |
| 700 | 1 | _aNorthfield, T C | |
| 773 | 0 |
_tEuropean journal of gastroenterology & hepatology _gvol. 12 _gno. 6 _gp. 695-700 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00042737-200012060-00020 _zAvailable from publisher's website |
| 999 |
_c10862285 _d10862285 |
||